Search clinical trials for: MBI 226 Acne Solutions

Total 285 results

BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Sepsis | Fungemia | Bacteremia

United States
Santen Inc.

Completed

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study

Open-angle Glaucoma, Ocular Hypertension

United States, Japan
Sanofi Pasteur, a Sanofi Company

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne

United States
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

Migraine Disorders

Japan
Metro International Biotech, LLC
Children's Hospital of Philadelphia

Completed

NAD+ Precursor Supplementation in Friedreich's Ataxia

Friedreich Ataxia

United States
Bayer

Completed

PK in Pts With HRPC & Skeletal Metastes

Prostatic Neoplasms

United Kingdom
United BioPharma

Recruiting

A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria

Taiwan
Celgene

Completed

Radiolabeled Study of AG-221 in Healthy Male Subjects.

Healthy Volunteers
Biocruces Bizkaia Health Research Institute
Sociedad Espanola de Angiologia y Cirugia Vascular

Recruiting

Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD) (IRONPAD)

Anemia | Peripheral Arterial Occlusive Disease

Spain
The Medicines Company
The Cleveland Clinic

Completed

MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial (PILOT)

Acute Coronary Syndrome

Poland, Netherlands, Hungary, Canada, Czechia
Chang Gung Memorial Hospital

Recruiting

Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Acne Vulgaris

Taiwan
Shanghai Medinno Pharmaceutical Technology Co.,...

Recruiting

A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults

Allergic Conjunctivitis

Australia
The Skin Center Dermatology Group

Recruiting

Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

Warts | Tinea | Actinic Keratosis | Bowen's Disease | Molluscum Contagiosum | Acne/Rosacea | Verruca Plana

United States
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Saline Injection Therapy in Atrophic Acne Scars

Scars | Atrophic

Pakistan
Northwestern University

Completed

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Acne

United States
Northwestern University

Recruiting

Investigational MRI Clinical Software and Hardware (Avery HS)

Image, Body

United States
Mayo Clinic

Withdrawn

High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy

Acute Kidney Injury | Acute Kidney Failure | Metabolic Acidosis

United States
Celgene

Completed

A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects (AME/FE)

Safety and Pharmacokinetics in Healthy Volunteer Subjects

United States
Veloce BioPharma LLC

Completed

A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

Chemotherapy-Associated Paronychia

United States
Mebiopharm Co., Ltd

Completed

Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors

Cancer

United States
Celgene

Completed

Radiolabeled Study of CC-220 in Healthy Male Subjects

Healthy Volunteer

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease

United States
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
Brigham and Women's Hospital
Boston Medical Center

Recruiting

NAD Augmentation in Diabetes Kidney Disease (DKD)

Diabetic Kidney Disease | Type2diabetes

United States
Bayer

Active, not recruiting

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Bone Metastatic Castration-resistant Prostate Cancer

United Kingdom, France, Lithuania, Israel, Italy, Austria
Microbio Co Ltd

Completed

Postbiotic MBS and Metformin Combination in Patients With T2DM

Type-II Diabetes

Taiwan
Brigham and Women's Hospital

Recruiting

Sirtuin-NAD Activator in Alzheimer's Disease

Dementia | Alzheimer's Disease (Incl Subtypes)

United States
Boehringer Ingelheim

Completed

The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers

Healthy
University Medicine Greifswald

Completed

Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®

MRI | Pharmacokinetics | Liver | Drug Transporter | Gd-EOB-DTPA

Germany
Pieris Australia Pty Ltd

Completed

Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects

Healthy

Australia
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer (Radium-223)

Prostate Cancer | Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)

United States
Livionex Inc.

Completed

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

Age Related Cataracts

United States
Stephen Trokel

No longer available

Progressive Keratoconus or Ectasia Treatment Plan

Keratoconus | Ectasia

United States
Celgene
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme...

Completed

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia (BELIEVE)

Beta-Thalassemia | Erythrocyte Transfusion

United States, Israel, Australia, Turkey, Taiwan, Malaysia, United Kingdom, Canada, Thailand, France, Lebanon, Italy, Bulgaria, Greece, Tunisia
Glaukos Corporation

Terminated

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Keratoconus

United States
Bayer

Completed

Japanese BAY88-8223 Monotherapy Phase II Study

Prostatic Neoplasms

Japan
Laboratorios Sophia S.A de C.V.

Not yet recruiting

Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF

Ocular Surface Disease | Dry Eye Disease
Aalborg University

Recruiting

Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity

Sleep Deprivation | Histamine | Cowhage

Denmark
Thomas Jefferson University

Terminated

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Pancreatic Cancer | Cholangiocarcinoma | Lymphadenopathy

United States
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer (RAD-THYR)

Thyroid Cancer

France
Stephen Trokel

Withdrawn

Higher Irradiance in Keratoconus Ectasia

Keratoconus | Ectasia

United States
Bayer

Terminated

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Breast Neoplasms

Spain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Germans Trias i Pujol Hospital; Grifols Biologicals, LLC; Banc de Sang i Teixits and other collaborators

Completed

Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients

SARS-CoV-2 Infection | Safety and Efficacy

Spain
Metro International Biotech, LLC

Completed

Phase 2a MIB-626 vs. Placebo COVID-19

Covid19 | Stage 1 Acute Kidney Injury

United States
United BioPharma

Not yet recruiting

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

Chronic Idiopathic Urticaria
University of Manitoba
Manitoba Pulse Growers

Completed

A Study to Examine the Glycemic Response of Corn and Soy Tortillas in Healthy Individuals (SOYT-2013)

Healthy

Canada
Celgene

Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Beta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

United States, Japan, Israel, United Kingdom, Turkey, Greece, Netherlands, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon
Santen Inc.

Completed

Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (ANGEL-2)

Primary Open Angle Glaucoma | Ocular Hypertension

United States

Search clinical trials for: MBI 226 Acne Solutions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations